Adalimumab for the treatment of ankylosing spondylitis

Author： Sieper Joachim   Rudwaleit Martin   Braun Jürgen  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.8, Iss.6, 2007-04, pp. : 831-838

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adalimumab on the map in ankylosing spondylitis

By  

Inpharma, Vol. 1, Iss. 1615, 2007-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Etoricoxib and the treatment of ankylosing spondylitis

By Lories Rik J  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 12, 2012-12 ,pp. : 1599-1608

Informa Healthcare

Access to resources Recommend Favorite

Adalimumab has worldly ambitions in ankylosing spondylitis

By  

Inpharma, Vol. 1, Iss. 1520, 2006-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Patients with ankylosing spondylitis (AS) who develop total spinal ankylosis still appear to benefit from treatment with adalimumab

By  

Inpharma, Vol. 1, Iss. 1659, 2008-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Efficacy and safety of adalimumab treatment in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis

By Poddubnyy Denis   Rudwaleit Martin  

Expert Opinion on Drug Safety, Vol. 10, Iss. 4, 2011-07 ,pp. : 655-673

Informa Healthcare

Access to resources Recommend Favorite